Inhibitors of monoamine oxidase B:pharmacology and clinical use in neurodegenerative disorders

Saved in:
Bibliographic Details
Group Author: Szelenyi I.; (Istvan), 1941-
Published: Birkhäuser,
Publisher Address: Basel Boston
Publication Dates: c1993.
Literature type: Book
Language: English
Series: Milestones in drug therapy
Subjects:
Carrier Form: xviii, 360 p.: ill. ; 24 cm.
ISBN: 3764327820 (alk. paper)
0817627820 (alk. paper)
Index Number: R971
CLC: R971
Call Number: R971/I55/
Contents: Includes bibliographical references and index.
Anatomy of the human basal ganglia / H. Braak and E. Braak -- Pathophysiological basis of Parkinson's Disease / M. Gerlach and P. Riederer -- Parkinson's Disease and its existing therapy / P.-A. Fischer -- Medicinal chemistry of present and future MAO-B inhibitors / J. Gaal and I. Hermecz -- l-deprenyl: a unique MAO-B inhibitor / E.E. Polymeropoulos -- Pharmacology of monoamine oxidase type B inhibitors / K. Magyar -- Pharmacological basis of the therapeutic effect of (-)-deprenyl in age-related neurological diseases / J. Knoll -- Neurotoxins and monoamine oxidase B inhibitors: possible mechanisms for the neuroprotective effect of (-)-deprenyl / V. Glover and M. Sandler -- Mode of action of MAO-B inhibitors / M. Gerlach, P. Riederer and M.B.H. Youdim -- Pharmacokinetics and clinical pharmacology of selegiline / E.H. Heinomen, M.I. Antila and R.A.S. Lammintausta -- Preclinical evaluation of l-deprenyl: lack of amphetamine-like abuse potential / S. Yasar ... [et al.]. (cont) History of l-deprenyl / M.J. Parnham -- MAO-B inhibitors in neurological disorders with special reference to selegiline / K. Wessel -- (-)-deprenyl combined with L-dopa in the treatment of Parkinson's Disease / T.S. Elizan -- Neuroprotective effects of MAO-B inhibition: clinical studies in Parkinson's Disease / P.A. LeWitt -- Alzheimer's Disease and l-deprenyl: rationales and findings / P.N. Tariot ... [et al.] -- Do MAO-B inhibitors have any role in the treatment of depression? / G. Laux -- Therapeutic place and value of present and future MAO-B inhibitors: l-deprenyl as the gold standard / P. Riederer and M.B.H. Youdim -- Chemical structures and pharmacological features of MAO-B inhibitors / W. Paul and I. Szelenyi -- Explanation of the nomenclature for optical isomers / E.E. Polymeropoulos.